News from glide technologies A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 01, 2017, 03:00 ET Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising

Glide Technologies, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today...


Jun 28, 2016, 04:00 ET Glide Technologies Announces Successful Clinical Proof-of-Concept Study with its Novel Octreotide Solid Dose Formulation Delivered via SDI®

Glide Technologies today announced results from a successful clinical proof-of-concept study that demonstrated its novel solid formulation of the...


May 19, 2016, 04:00 ET Glide Technologies Initiates Clinical Proof-of-Concept Study with Novel Octreotide Solid Dose Formulation Delivered via Needle-Free SDI®

Glide Technologies, the pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines, today...


Jan 06, 2016, 04:00 ET Glide Technologies Announces Successful Proof-of-Concept With Novel Exenatide Solid Dose Formulation

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines, today announced that the Company has...


Sep 21, 2015, 04:00 ET Glide Technologies Announces Collaboration With Cilian AG to Develop Novel Solid Dose Recombinant Influenza Vaccine

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines, today announced that it has entered a...


Apr 23, 2015, 04:00 ET Glide Technologies Completes Successful Proof-of-Concept Study With Novel Solid Dose Formulation of Teriparatide SDI®

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today...


Mar 16, 2015, 05:00 ET Glide Announces Successful Results from Skin Delivery and Human Factor Studies with Novel Solid Dose Injection System

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today...


Mar 09, 2015, 05:00 ET Pfenex Exercises Glide Contract Extension for Solid Dose Formulation of Recombinant Protective Antigen (rPA)-Based Anthrax Vaccine

Glide Technologies announced today a subcontract extension for the advancement of an alternative delivery method for Pfenex's recombinant Protective...